Joshua S. Boger, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 8,000 shares at $84.98 ($660K) on 2017-01-11, disclosed to the SEC on 2017-01-13.
Scheduled sale ($660k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $81.25 | 2,400 | $195K | 29.6% |
| 2 | $82.17 | 2,900 | $238K | 36.1% |
| 3 | $82.92 | 1,100 | $91K | 13.8% |
| 4 | $84.41 | 1,100 | $93K | 14.1% |
| 5 | $84.98 | 500 | $42K | 6.4% |
| Total | $82.48 avg | 8,000 |
| $660K |
| 100% |
| Filing → |
| VRTX | SELL | 2017-01-03 | $483K | — | Filing → |
| VRTX | SELL | 2016-12-22 | $482K | — | Filing → |
| VRTX | SELL | 2016-12-16 | $504K | — | Filing → |